Anthem, Inc. (ANTM) Position Boosted by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. raised its position in Anthem, Inc. (NYSE:ANTM) by 80.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,583,761 shares of the company’s stock after purchasing an additional 706,775 shares during the quarter. UBS Asset Management Americas Inc. owned 0.60% of Anthem worth $297,953,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in ANTM. Captrust Financial Advisors acquired a new stake in shares of Anthem in the second quarter valued at about $128,000. Westside Investment Management Inc. grew its stake in Anthem by 33.6% during the 1st quarter. Westside Investment Management Inc. now owns 795 shares of the company’s stock valued at $131,000 after purchasing an additional 200 shares in the last quarter. Focused Wealth Management Inc acquired a new stake in Anthem during the 1st quarter valued at approximately $149,000. Cedar Wealth Management LLC grew its stake in Anthem by 1.7% during the 2nd quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock valued at $171,000 after purchasing an additional 15 shares in the last quarter. Finally, Guardian Life Insurance Co. of America grew its stake in Anthem by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,016 shares of the company’s stock valued at $168,000 after purchasing an additional 7 shares in the last quarter. Institutional investors own 87.65% of the company’s stock.
Shares of Anthem, Inc. (NYSE ANTM) traded down 1.39% during trading on Tuesday, hitting $182.43. The stock had a trading volume of 941,894 shares. The stock’s 50 day moving average is $191.73 and its 200 day moving average is $182.14. The stock has a market capitalization of $47.90 billion, a price-to-earnings ratio of 17.25 and a beta of 0.70. Anthem, Inc. has a 52 week low of $114.85 and a 52 week high of $198.98.
Anthem (NYSE:ANTM) last issued its quarterly earnings results on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The company had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $22.25 billion. During the same quarter in the prior year, the company earned $3.33 EPS. Anthem’s quarterly revenue was up 4.3% on a year-over-year basis. On average, equities research analysts expect that Anthem, Inc. will post $11.83 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend is Thursday, September 7th. This is an increase from Anthem’s previous quarterly dividend of $0.65. Anthem’s dividend payout ratio is 26.52%.
ANTM has been the subject of a number of recent analyst reports. Morgan Stanley initiated coverage on Anthem in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $196.00 price objective for the company. Citigroup Inc. restated a “buy” rating and set a $205.00 price objective on shares of Anthem in a research note on Wednesday, June 28th. Credit Suisse Group initiated coverage on Anthem in a research note on Wednesday, July 12th. They set a “neutral” rating and a $195.00 price objective for the company. Deutsche Bank AG raised their price objective on Anthem from $173.00 to $185.00 and gave the company a “hold” rating in a research note on Thursday, July 13th. Finally, Bank of America Corporation raised their price objective on Anthem from $224.00 to $228.00 and gave the company a “buy” rating in a research note on Friday, July 14th. Ten research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $183.44.
ILLEGAL ACTIVITY NOTICE: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/19/anthem-inc-antm-position-boosted-by-ubs-asset-management-americas-inc.html.
In other news, EVP Thomas C. Zielinski sold 9,127 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $191.25, for a total transaction of $1,745,538.75. Following the sale, the executive vice president now owns 26,571 shares of the company’s stock, valued at approximately $5,081,703.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Julie A. Hill sold 524 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $190.80, for a total transaction of $99,979.20. Following the sale, the director now directly owns 36,924 shares in the company, valued at approximately $7,045,099.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 30,776 shares of company stock worth $6,007,143. 0.36% of the stock is owned by corporate insiders.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Stock Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related stocks with our FREE daily email newsletter.